reports
- David Carlson
- David Nierengarten
- Dennis Pak
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Sam Ravina
NTLA INTELLIA THERAPEUTICS INC.
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
REPL REPLIMUNE GROUP
YMAB Y-MABS THERAPEUTICS
SWTX SPRINGWORKS THERAPEUTICS
BDTX BLACK DIAMOND THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
COGT COGENT BIOSCIENCES INC
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
IKNA IKENA ONCOLOGY INC
TCRX TSCAN THERAPEUTICS INC
HOWL WEREWOLF THERAPEUTICS INC
CMPX COMPASS THERAPEUTICS
Customers Bancorp, Inc. Announces Dividend Correction on Its Series E ...
WEST READING, Pa.--(BUSINESS WIRE)-- Customers Bancorp, Inc. (NYSE:CUBI) announced a corrected dividend amount on its Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series E (NYSE: CUBIPrE) and Series F (NYSE: CUBIPrF), previously announced on April 29, 2024. As corrected, the cash dividend on its Series E (NYSE: CUBIPrE) will be $0.700488 per share, payable on June 17, 2024, to shareholders of record on May 31, 2024, and the cash dividend on its Series F (NYSE: CUBIPrF) will be $0.675813 per share, payable on June 17, 2024, to shareholders of record on May 31, 2024. Instit...
- Wedbush Research
XENE XENON PHARMACEUTICALS INC
V VISA INC. CLASS A
TSCO TRACTOR SUPPLY COMPANY
TRIP TRIPADVISOR INC.
SAGE SAGE THERAPEUTICS INC.
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
HURN HURON CONSULTING GROUP INC.
GOOGL ALPHABET INC. CLASS A
FL FOOT LOCKER INC.
FATE FATE THERAPEUTICS INC
EXPE EXPEDIA GROUP INC.
DECK DECKERS OUTDOOR CORPORATION
BPMC BLUEPRINT MEDICINES CORP.
BIIB BIOGEN INC.
AZO AUTOZONE INC.
ARDX ARDELYX INC
AAP ADVANCE AUTO PARTS INC.
KO COCA-COLA COMPANY
TSC TRISTATE CAPITAL HOLDINGS INC
ORLY O'REILLY AUTOMOTIVE INC.
PK PARK HOTELS & RESORTS INC.
CVCO CAVCO INDUSTRIES INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
GM GENERAL MOTORS COMPANY
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
BKNG BOOKING HOLDINGS INC.
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
LYFT LYFT
UBER UBER TECHNOLOGIES INC.
CHWY CHEWY INC. CLASS A
STOK STOKE THERAPEUTICS
SWTX SPRINGWORKS THERAPEUTICS
LC LENDINGCLUB CORP
IDYA IDEAYA BIOSCIENCES
GDYN GRID DYNAMICS
BDTX BLACK DIAMOND THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
COGT COGENT BIOSCIENCES INC
DASH DOORDASH
ABNB AIRBNB INC. CLASS A
IMNM IMMUNOME
VOR VOR BIOPHARMA
WOOF PETCO HEALTH AND WELLNESS
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
LBPH LONGBOARD PHARMACEUTICALS
FOUR SHIFT4 PAYMENTS
IKNA IKENA ONCOLOGY INC
TCRX TSCAN THERAPEUTICS INC
HOWL WEREWOLF THERAPEUTICS INC
FLYW FLYWIRE CORP
GLUE MONTE ROSA THERAPEUTICS INC
CMPX COMPASS THERAPEUTICS
GMTX GEMINI THERAPEUTICS INC
CINT CI&T INC
YOU CLEAR SECURE INC
TOST TOAST INC
HR HEALTHCARE TRUST OF AMERICA INC.
EWTX EDGEWISE THERAPEUTICS INC
NUVL NUVALENT INC
EMBRAC B EMBRACER GROUP AB
- David Carlson
- David Nierengarten
- Dennis Pak
- Martin Fan
- Ritika Das
- Robert Driscoll
- Sam Ravina
NVCR NOVOCURE LTD.
FL FOOT LOCKER INC.
FATE FATE THERAPEUTICS INC
BPMC BLUEPRINT MEDICINES CORP.
TSC TRISTATE CAPITAL HOLDINGS INC
PK PARK HOTELS & RESORTS INC.
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
GM GENERAL MOTORS COMPANY
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
SWTX SPRINGWORKS THERAPEUTICS
LC LENDINGCLUB CORP
IDYA IDEAYA BIOSCIENCES
BDTX BLACK DIAMOND THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ORIC ORIC PHARMACEUTICALS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
COGT COGENT BIOSCIENCES INC
IMNM IMMUNOME
VOR VOR BIOPHARMA
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
IKNA IKENA ONCOLOGY INC
TCRX TSCAN THERAPEUTICS INC
HOWL WEREWOLF THERAPEUTICS INC
GLUE MONTE ROSA THERAPEUTICS INC
CMPX COMPASS THERAPEUTICS
GMTX GEMINI THERAPEUTICS INC
HR HEALTHCARE TRUST OF AMERICA INC.
NUVL NUVALENT INC
Northrop Grumman to Participate in Bernstein’s 40th Annual Strategic D...
Northrop Grumman to Participate in Bernstein’s 40th Annual Strategic Decisions Conference FALLS CHURCH, Va., May 23, 2024 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) will participate in Bernstein’s 40th Annual Strategic Decisions Conference on Thursday, May 30. Kathy Warden, chair, chief executive officer and president, will present beginning at 9:00 a.m. Eastern time. The presentation will be webcast live at . Northrop Grumman is a leading global aerospace and defense technology company. Our pioneering solutions equip our customers with the capabilities they need to con...
Northrop Grumman’s B-21 Raider Continues Its Flight Test Campaign
Northrop Grumman’s B-21 Raider Continues Its Flight Test Campaign The B-21 Raider continues its flight test campaign at Edwards Air Force Base, California. (Photo Credit: Northrop Grumman) EDWARDS AIR FORCE BASE, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- (PHOTO RELEASE) Northrop Grumman Corporation’s (NYSE: NOC) B-21 Raider continues its flight test campaign at Edwards Air Force Base, California, led by a Combined Test Force (CTF) comprised of Northrop Grumman and U.S. Air Force personnel. CTF test pilots indicate the jet is performing as expected with the aircraft flying like the simul...
Northrop Grumman Corp: 1 director
A director at Northrop Grumman Corp sold 910 shares at 471.900USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
- Wedbush Research
WSM WILLIAMS-SONOMA INC.
WDC WESTERN DIGITAL CORPORATION
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
OHI OMEGA HEALTHCARE INVESTORS INC.
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
FB FACEBOOK INC. CLASS A
BBY BEST BUY CO. INC.
AXTI AXT INC.
NFLX NETFLIX INC.
SWKS SKYWORKS SOLUTIONS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
VFC V.F. CORPORATION
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
SRRK SCHOLAR ROCK HOLDING CORPORATION
SMCI SUPER MICRO COMPUTER
WOOF INC.
STX PETCO HEALTH AND WELLNESS
SEAGATE TECHNOLOGY HLDGS PLC
- David Carlson
- David Nierengarten
- Dennis Pak
- Martin Fan
Antero Resources Corp: 1 director
A director at Antero Resources Corp sold 16,377 shares at 35.500USD and the significance rating of the trade was 66/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
HII to Participate in Bernstein’s 40th Annual Strategic Decisions Conf...
HII to Participate in Bernstein’s 40th Annual Strategic Decisions Conference on May 29 NEWPORT NEWS, Va., May 22, 2024 (GLOBE NEWSWIRE) -- HII (NYSE: HII) will participate in Bernstein’s Strategic Decisions Conference on May 29. The conversation with HII President and Chief Executive Officer Chris Kastner will begin at 1:30 p.m. Eastern time and will be webcast on . About HII HII is a global, all-domain defense provider. HII’s mission is to deliver the world’s most powerful ships and all-domain solutions in service of the nation, creating the advantage for our customers to protect peace...
Huntington Ingalls Industries Inc: 1 director
A director at Huntington Ingalls Industries Inc sold 1,500 shares at 256.068USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...
Scholar Rock Announces Initiation of Phase 2 EMBRAZE Trial of Apitegro...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases where protein growth factors play a fundamental role, today announced the initiation of the Phase 2 EMBRAZE proof-of-concept trial, designed to assess the safety and efficacy of apitegromab, a highly selective myostatin inhibitor, to preserve lean muscle mass in individuals living with obesity and on background therapy of a GLP-1 receptor agonist (GLP-1 RA). The...
Chemung Financial Corporation Announces Quarterly Dividend
Chemung Financial Corporation Announces Quarterly Dividend ELMIRA, N.Y., May 21, 2024 (GLOBE NEWSWIRE) -- Chemung Financial Corporation (Nasdaq: CHMG) announced today that its Board of Directors has approved a quarterly cash dividend of $0.31 per share, payable on July 1, 2024, to common stock shareholders of record as of the close of business on June 17, 2024. Chemung Financial Corporation is a $2.8 billion financial services holding company headquartered in Elmira, New York and operates 31 offices through its principal subsidiary, Chemung Canal Trust Company, a full-service community...
HII Mission Technologies CFO Receives WashingtonExec’s Chief Officer A...
HII Mission Technologies CFO Receives WashingtonExec’s Chief Officer Award McLEAN, Va., May 21, 2024 (GLOBE NEWSWIRE) -- HII (NYSE: HII) executive Ashutosh Gokhale was honored at WashingtonExec’s Chief Officer Awards ceremony, held on May 10 in McLean. Gokhale, who serves as chief financial officer and senior vice president of business management at HII’s Mission Technologies division, won the Public Company CFO of the Year award. Gokhale was recognized for a range of business management improvements he led in 2023, including consolidation of an Enterprise Reporting Management system; im...
HII Launches “Build It” Campaign to Highlight Shipbuilder Support for ...
HII Launches “Build It” Campaign to Highlight Shipbuilder Support for U.S. Navy NEWPORT NEWS, Va., May 21, 2024 (GLOBE NEWSWIRE) -- As New York City hosts the annual Fleet Week in celebration of the nation’s sea services, HII (NYSE: HII) — the nation’s largest military shipbuilder and a sponsor of the Intrepid Museum’s commemoration of the event — is launching a hiring campaign to spotlight the contributions and rewards of building ships for the U.S. Navy. The HII “Build It” campaign is dedicated to the men and women who partner with the U.S. Navy to build ships critical to the national ...
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declare...
CINCINNATI--(BUSINESS WIRE)-- Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2024 annual stockholders’ meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company’s independent accountants for 2024. Stockholders also approved Chemed’s executive compensation. In addition, stockholders voted against the stockholder proposal on ratification of termination pay. Dividend Declared Following the stockholders’ meeting, Chemed’s Board of Directors declared a quarterly cash dividend of 40 cents per share on the ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.